Using advanced imaging to locate obscure tumours and hard-to-detect cancers to facilitate early diagnosis
What does this
Imaging is central to the management of cancer patients. There has been a recent drive to advance cancer therapeutics (e.g. anti-vascular agents, stem-cell drug delivery, minimally invasive focal therapies etc.). For the benefits of these novel approaches to be realized there is now an equal necessity to develop and validate appropriate imaging techniques to monitor therapeutic delivery and assess therapeutic response. Across the campus UCL is developing cutting-edge novel imaging to facilitate early diagnosis, provide improved disease staging, select personalized treatment plans, provide more sensitive and therapy specific methods to assess treatment response and reduce the overall diagnostic radiation burden.
The UCL cancer imaging program is delivered through multi-disciplinary teams of oncologists, surgeons, radiologists, nuclear medicine physicians, histopathologists, physicists and radiographers together with basic scientists and image computing specialists. These teams through UCL Partners have access to a patient population of over 6 million together with multiple advanced pre-clinical and clinical scanners, including the first clinical and fully operational whole-body PET-MRI installation in the UK.
Partners and Facilities
The UCL cancer imaging program is delivered through multi-disciplinary teams of oncologists, surgeons, radiologists, nuclear medicine physicians, histopathologists, physicists and radiographers together with basic scientists and image computing specialists. We are uniquely placed to offer the best in research from the Centre for Medical Image Computing, the Institute of Biomedical Engineering and the Centre for Medical Imaging alongside the clinicians from University College London Hospital and the Royal Free Hospital. These teams through UCL Partners have access to a patient population of over 6 million together with multiple advanced pre-clinical and clinical scanners, including the first clinical and fully operational whole-body PET-MRI installation in the UK.
Studying Under This Theme
Projects listed below are available for applicants to include in their 5 project choices. Successful candidates will meet with both primary supervisors from their selection before being assigned to their allocated research project to ensure that each student gets the best opportunity for their skills and development. To view all available project videos please visit our YouTube Channel.
Shonit Punwani is a Senior Lecturer in Oncological Imaging at University College London and Honorary Consultant Radiologist specialising in oncological radiology at University College London Hospital (UCLH). He has an additional postgraduate qualification in MRI Physics and is responsible for the 3T MR Research Facility at UCLH, which is developing novel MRI techniques for first-in-man oncological imaging studies. He has a specialist clinical and research interest in the application and development of quantitative functional MRI for the detection and monitoring of prostate cancer and its treatments.
More about our Clinical Research
- Industry Seminar: From White Boards to White Coats with Prof Sir Michael Brady
- Cancer Infographic - Men Vs Women
- "Imaging cancer with MRI - how engineering can make a difference"
- Clinical Seminar: Transforming our approach to the diagnosis and treatment of liver, biliary tract and pancreatic cancers
- Recruitment time for the EPSRC CDT in Medical Imaging
- Molecular Imaging in the Clinic - Status, Opportunities & Issues
- Visit us at the UCL Graduate Open Day
- Ask our STEM Ambassadors: Focus on Nooshin Ghavami
- Complex ultrasound signals created by light
- Image-guided treatment of pancreaticobiliary tumours
- Keynote Lecture and Directors Welcome 2017